Flash Finance

📈 Live Market Tracking

AI-Powered NSE Corporate Announcements Analysis

34875
Total Announcements
11439
Positive Impact
1913
Negative Impact
19277
Neutral
Clear
DMCC Seeks Shareholder Approval for MD Re-appointment and Board Changes
DMCC Speciality Chemicals has initiated a postal ballot to seek shareholder approval for the re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a three-year term effective April 1, 2026. The company is also proposing the appointment of Saloni Jhaveri as a Women Independent Director for a five-year term and a revision in the remuneration of Executive Director Kuldeep Kumar Tiwari. Additionally, resolutions include the alteration of the Memorandum of Association and adoption of new Articles of Association. The e-voting process concludes on March 15, 2026, with results expected by March 17, 2026.
Key Highlights
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term (2026-2029) Appointment of Saloni Jhaveri as Women Independent Director for a 5-year term starting January 2026 Revision of remuneration for Kuldeep Kumar Tiwari, Executive Director (Operations), effective April 1, 2026 Proposed updates to the Memorandum of Association (MoA) and Articles of Association (AoA) E-voting period scheduled from February 13, 2026, to March 15, 2026
💼 Action for Investors Investors should support the resolutions to ensure leadership continuity, while keeping an eye on the specific details of the remuneration revision in the full explanatory statement.
DMCC Q3FY26 Revenue Up 28% YoY to ₹151 Cr; PAT Declines 22% on Margin Pressure
DMCC reported a strong 27.81% YoY growth in revenue to ₹150.87 crore for Q3FY26, driven by the resumption of the Boron business and improved realisations. However, EBITDA margins contracted significantly by 543 bps to 9.87% as elevated sulphur costs and a higher revenue base impacted percentages. While quarterly PAT fell 21.64% YoY to ₹6.17 crore, the 9-month performance remains robust with 9MFY26 PAT up 30.68% at ₹19.67 crore. The company expects the Boron segment to contribute ₹125-150 crore in annual revenue moving forward.
Key Highlights
Revenue from operations grew 27.81% YoY to ₹150.87 crore in Q3FY26. EBITDA margins compressed by 543 bps YoY to 9.87% due to high raw material costs and pricing divergence. Resumed Boron operations are projected to generate ₹125-150 crore in annual revenue. 9MFY26 PAT increased by 30.68% to ₹19.67 crore compared to ₹15.06 crore in 9MFY25. Sustainability initiatives now contribute over 80% of the company's energy requirements through solar and waste heat recovery.
💼 Action for Investors Investors should monitor the stabilization of margins as the company navigates volatile sulphur prices and the full-scale ramp-up of the Boron business. The strong 9-month cumulative growth suggests underlying resilience despite the quarterly margin hit.
DMCC Re-appoints Bimal Goculdas as MD & CEO for 3 Years; Approves Q3 FY26 Results
DMCC Speciality Chemicals has approved the re-appointment of Bimal Lalitsingh Goculdas as Managing Director and CEO for a three-year term starting April 2026. The board also approved an increase in remuneration for Executive Director Kuldeep Kumar Tiwari and proposed significant updates to the company's Memorandum and Articles of Association to align with the Companies Act 2013. While the Q3 FY26 financial results were approved, the specific P&L figures were not detailed in the provided cover letter, though the auditor's review report was clean. These changes aim to provide better operational flexibility and governance alignment for the company.
Key Highlights
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term from April 1, 2026, to March 31, 2029. Proposed increase in remuneration for Shri Kuldeep Kumar Tiwari, Executive Director (Operations), subject to postal ballot approval. Comprehensive update of Memorandum of Association (MOA) and Articles of Association (AOA) to align with the Companies Act 2013. Approval of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. The board meeting commenced at 1:00 p.m. and concluded at 3:05 p.m. on February 6, 2026.
💼 Action for Investors Investors should view the leadership continuity as a sign of stability for the company's long-term strategy. Monitor the upcoming Postal Ballot results and the detailed Q3 financial performance once fully released to assess operational growth.
BOARD_MEETING NEUTRAL 6/10
DMCC Approves Q3 Results, Re-appoints CEO, and Proposes MOA/AOA Amendments
DMCC Speciality Chemicals has approved its unaudited financial results for Q3 FY26 and announced the re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a three-year term starting April 2026. The board also proposed significant amendments to the Memorandum and Articles of Association (MOA/AOA) to align with the Companies Act 2013 and provide greater operational flexibility for future activities. Additionally, a remuneration increase for the Executive Director of Operations was approved, subject to shareholder consent. These moves indicate a focus on leadership continuity and regulatory compliance.
Key Highlights
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term from April 2026 to March 2029. Proposed amendments to MOA Object and Liability clauses to align with Companies Act 2013 and enable future business flexibility. Approval of remuneration increase for Kuldeep Kumar Tiwari, Executive Director (Operations), pending shareholder approval. Consolidated results include subsidiary DMCC (Europe) GMBH, which contributed a nominal Rs 3.35 lacs to Q3 revenue. Shareholder approval for management and regulatory changes to be sought via Postal Ballot.
💼 Action for Investors Investors should monitor the upcoming Postal Ballot notice for specific details on the expanded 'Object Clause' to identify potential new business segments. Leadership continuity is a positive sign for management stability.
BOARD_MEETING NEUTRAL 6/10
DMCC Speciality Chemicals Approves Q3 FY26 Results and Re-appoints Bimal Goculdas as MD & CEO
DMCC Speciality Chemicals has approved its unaudited financial results for the quarter ended December 31, 2025, alongside key leadership decisions. The board confirmed the re-appointment of Bimal Lalitsingh Goculdas as MD and CEO for a three-year term effective April 2026, ensuring management continuity. Additionally, the company is seeking shareholder approval to amend its Memorandum of Association (MOA) to provide greater operational flexibility for future business activities. While the main entity's specific profit figures were not detailed in the text, its European subsidiary reported a marginal profit of ₹0.86 lacs for the quarter.
Key Highlights
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term (2026-2029). Proposed increase in remuneration for Kuldeep Kumar Tiwari, Executive Director (Operations). Amendment of MOA 'Main Objects' clause to allow for future business expansion and flexibility. Adoption of new Articles of Association (AOA) to align with the Companies Act, 2013. Subsidiary DMCC (Europe) GMBH reported a net profit of ₹0.86 lacs for the quarter ended Dec 31, 2025.
💼 Action for Investors Investors should review the full financial statements once published to assess core profitability trends. The management continuity is a positive sign, but the proposed changes to the MOA objects clause should be monitored for signs of diversification into new business segments.
DMCC: Supreme Court rules in favor regarding 52-acre land
DMCC Speciality Chemicals has announced that the Supreme Court of India ruled in its favor regarding a civil appeal. The appeal concerned a 52-acre piece of land in Nalimbi, near Ambernath, Taluka, Kalyan, which the government of Maharashtra had previously designated as Forest Land under The Maharashtra Private Forest (Acquisition) Act, 1975. The Supreme Court's decision quashes the previous orders and declarations, directing corrections in revenue records. DMCC will now take necessary steps as advised, potentially unlocking value from this land.
Key Highlights
Company owns 52 acres of land at village Nalimbi Land was acquired under The Maharashtra Private Forest (Acquisition) Act, 1975 Civil appeal was filed before Supreme Court of India (SCI) Supreme Court quashed orders treating land as 'Forest Land'
💼 Action for Investors Investors should monitor DMCC's actions regarding the 52-acre land and any potential impact on the company's financials. This ruling could positively affect the company's asset value.
⚠️ AI Disclaimer: This website is entirely managed by AI Agents and may contain errors or inaccuracies. Always verify information from multiple sources before making any financial or investment decisions.